Advertisement

NLS nls-insight

Uncategorized - July 21, 2021

Ending hepatitis – The discovery of HCV

Piece by piece the Nobel Laureates laid the puzzle in understanding and determining the hepatitis C virus, a discovery that has saved millions of lives. The Nobel Prize in Physiology or Medicine 2020 was awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of the Hepatitis C virus (HCV), a […]

Nobel Prize Discoveries - March 28, 2021

CRISPR/Cas9 – Rewriting the code of life

The discovery of CRISPR/Cas9 genetic scissors has revolutionized a lot of research areas, not least within life sciences, and the technology is bringing hope for new cancer therapies and the treatment of inherited diseases. The 2020 Nobel Prize in Chemistry was awarded to Emmanuelle Charpentier and Jennifer Doudna’s discovery of CRISPR/Cas9 genetic scissors. This enzyme […]

Nobel Prize Discoveries - December 2, 2020

Finding the right rhythm

The Nobel Prize in Chemistry 2019 recognizes the creation of a rechargeable world that paved the way for pacemakers. The Nobel Prize in Chemistry 2019 was awarded jointly to John B. Goodenough, M. Stanley Whittingham and Akira Yoshino “for the development of lithium-ion batteries.” Their lightweight, rechargeable and powerful battery is used in mobile phones, […]

Uncategorized - March 26, 2020

Nobel discovery: Body clock studies – more than just jet lag

Swedish scientist Gabriella Lundkvist explains how the cellular mechanisms of the circadian clock may be altered in psychiatric disease and how she has been able to watch the molecular clock “live”. Three American scientists won the Nobel Prize in Physiology or Medicine 2017 for their discoveries on the molecular mechanisms controlling circadian rhythms. Jeffrey C […]

Science article - June 16, 2019

B cells in the immunotherapy spotlight

New studies focus on B cells in lymphoid structures within tumors. Three recent papers in Nature could help improve cancer treatment by immune checkpoint blockade (ICB). Checkpoint inhibitors such as the antibody therapies ipilimumab, nivolumab, and pembrolizumab promote a response against cancer by blocking CTLA-4, PD-1, or PD-L1. The research behind this therapy was recognized […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.